Paterson A.H., Powles T.J., Kanis J.A,
è ñîàâò. Double blind controlled trial of oral
clodronate in patients with bone metastases from breast cancer // J. Clin. Oncol. — 1993. —
V. 11. — P. 59 65.
Paterson A.H., Kanis J.A., Powles T.J., McCloskey E., Hanson J., Ashley S.
Role of
bisphosphonates in prevention and treatment of bone metastases from breast cancer //
Can. J. Oncol. — 1995. — V. 5 (Suppl. 1). — P. 54 57.
Paterson A.H
. Should bisphosphonates be standard therapy for bone pain? //
Support Care Cancer. — 1997. — V. 5(3). — P. 200 204.
Patt L.M., Houck J.C.
Role of polypeptide growth factors in normal an abnormal
growth // Kidney Int. — 1983. — V. 23. P. 603 610.
Pauwels E., Heslinga J.M., Zwareling A.
Value of pretreatment and follow up skele
tal scintigraphy in operable breast cancer // Clin. Oncol. — 1982. — V. 8.(1). — P. 25 32.
Pauwels E., Schutte H.E., Arudt J.
Bone scintigraphy in oncology: an update with
emphasis on efficacy and cost efectiveness // Diagnostic Im. in Clin. Med. — 1986. —
V. 55(6). — P. 314 320.
Peacock M., Robertson W.G., Nordin N.
Relation brtween serum and urinary calci
um with particular reference to parathyroid hormone // Lancet. — 1969. — V. 1. — P. 384
386.
Peethambaram P.P., Ingle J.N., Suman V.J., Hartmann L.C., Loprinzi C.L.
Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with
metastatic breast cancer. An updated analysis // Breast Cancer Res. Treat. — 1999. —
V. 54(2). — P. 117 122.
Pene F., Ichlienger M., Ichmitt T., Izrael V., Kinay M.
Half body irradiation for pain
relief // Eur. J. Cancer Clin. Oncol. — 1981. — V. 17(7). — P.753 758.
Penn C.R.H.
Single dose and fractionated palliative irradiation for osseous metas
tases // Clin. Radiol. — 1976. — V. 27. — P.405 408.
Percival R.C., Yates A.J.P., Gray R.E.S.
è ñîàâò. Role of glucocrticoids in manag
ment of malignant hypercalcaemia // Br. Med. J. — 1984. — V. 289 — P. 287.
Percival R.C., Yates A.J.P., Gray R.E.S.
è ñîàâò. Mechanisms of hypercalcaemia in
carcinoma of the breast // Br. Med. J. — 1985. — V. 291. — P. 776 779.
Percudani M., Dell`Anna B., Delorenzio G.F.
è ñîàâò. Hydrocsiproline and zink
excretiol in patients with neoplastic breast disease // Int. Surg. — 1981. — V. 66. —
P. 233 236.
Peres D.J., Powles T.J., Milan J.
è ñîàâò. Detection of breast carcinoma metastases
in bone: relative merits of X ray and skeletal scintigraphy // Lancet V. — 1983. —V. 8350. —
P. 613 614.
Perez C.A., Bradfield J.S., Morgan H.C.
Managment of pathologic fractures //
Cancer. — 1972. — V. 79. — P. 684 693.
Perez J.E., Machiavelli M., Leone B.A.
Bone — only versus visceral — only metasta
tic patterns in breast cancer: analysis of 150 patients // A. C.O.G. Study. Am. Clin. Oncol. —
1990. — V.13 (4). — P. 294 298.
Perez E.A., Irwin D.H., Patel R., Vogel C.L., Kirshner J.
A large phase II trial of pacli
taxel administered as a weekly one hour infusion in patients with metastatic breast cancer
(Abstract 480) // American Society of Clinical Oncology. — 35th Annual Meeting, Atlanta. —
1999.
Perry M.C., Kardinal C.G., Korzun A.H., Ginsberg S., Raich P.C. è ñîàâò.
Chemohormonal therapy in advanced carcinoma of the breast: cancer and leukemia group
B protocol 8081 // J. Clin. Oncol. — 1987. — V. 5. — P. 1534 1545.
242
Êîñòíûå ìåòàñòàçû ðàêà ìîëî÷íîé æåëåçû
